Zikani Therapeutics

Zikani Therapeutics

Zikani Therapeutics

Zikani Therapeutics, a Watertown, Mass.-based developer of novel ribosome modulating agents (RMAs) for the treatment of rare, nonsense mutation-driven diseases.
Raised
$7.5M
Follow us
Latest funding
$7,500,000
Venture capital (Series A) - 2020
Roche Venture Fund Advent Life Sciences Gurnet Point Capital
Team Size
1–10
Employees
$7,500,000 Venture capital (Series A)
FinSMEs

Zikani Therapeutics Closes $7.5M Series A-1 Funding